Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 55: 533-540, 2009. First published January 23, 2009; 10.1373/clinchem.2008.116707
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2008.116707v1
55/3/533    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baird, G. S.
Right arrow Articles by Chandler, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baird, G. S.
Right arrow Articles by Chandler, W.
(Clinical Chemistry. 2009;55:533-540.)
© 2009 American Association for Clinical Chemistry, Inc.

Evidence-based Medicine and Test Utilization

Reducing Routine Ionized Calcium Measurement

Geoffrey S. Baird1,a, Petrie M. Rainey1, Mark Wener1 and Wayne Chandler1

1 Department of Laboratory Medicine, University of Washington, Seattle, Washington.

aAddress correspondence to this author at: University of Washington, Department of Laboratory Medicine, Box 357110, 1959 NE Pacific St., Seattle, WA 98195-7110. Fax (206) 598-6189; e-mail gbaird{at}u.washington.edu.

Background: Ionized calcium (iCa) is measured frequently in hospitalized patients, and hypocalcemia is frequently found, seemingly supporting the practice.

Methods: We retrieved the results of 58 040 iCa tests and records of intravenous (IV) and oral calcium supplementation from laboratory and hospital information systems and evaluated them for frequency of testing, frequency of hypocalcemia, and effects of calcium supplementation.

Results: Serial and daily iCa testing was common and responsible for a substantial fraction of all iCa tests ordered. Half of all patients tested had iCa values below the reference interval. IV, but not oral, calcium therapy increased mean iCa concentrations, but the effect of calcium administration was small compared with the spontaneous increase in iCa that occurred in similar patients who received no calcium treatment. A retrospective analysis suggested that a low total calcium (tCa) concentration (<2.00 mmol/L, <8 mg/dL) could identify most patients with low iCa (<1.0 mmol/L). Introduction of a reflexive strategy reduced iCa testing by 72%–76% and reduced IV calcium gluconate therapy by 45%–81%.

Conclusions: Testing for iCa and IV calcium supplementation were significantly reduced with a reflexive calcium testing strategy that provided iCa testing only to patients with low tCa. Adverse clinical outcomes possibly associated with hypocalcemia did not increase.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Association for Clinical Chemistry.